Daniel R. Hart is CFO at Avid Bioservices, Inc. (CDMO). They have made 18 open-market trades across 1 company since 2020, most recently 2025-02-05.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 18 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CDMO | 112,735 | $1.4M |
Shares reported on the most recent Form 4, priced at the 2025-01-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CDMO | SELL | 2024-12-26 | 2024-12-27 | $12.22 | $534K | +1.0% | +1.3% | N/A |
| CDMO | SELL | 2024-04-30 | 2024-05-02 | $7.40 | $21K | +10.7% | -4.1% | +25.6% |
| CDMO | SELL | 2024-01-10 | 2024-01-11 | $6.17 | $15K | -2.5% | +9.2% | +1.9% |
| CDMO | SELL | 2023-10-10 | 2023-10-11 | $9.20 | $19K | -22.7% | -44.6% | -31.6% |
| CDMO | SELL | 2023-07-11 | 2023-07-12 | $13.86 | $104K | -0.6% | -4.0% | -29.1% |
| CDMO | SELL | 2023-07-10 | 2023-07-11 | $13.77 | $17K | +2.2% | -5.7% | -30.7% |
| CDMO | SELL | 2023-06-29 | 2023-06-30 | $12.70 | $175K | -2.6% | -7.8% | -29.2% |
| CDMO | SELL | 2023-04-10 | 2023-04-11 | $19.80 | $25K | -3.9% | -14.5% | -31.9% |
| CDMO | SELL · 10b5-1 | 2023-04-05 | 2023-04-07 | $19.00 | $24K | -1.0% | -8.9% | -30.6% |
| CDMO | SELL | 2023-03-14 | 2023-03-16 | $19.00 | $95K | +1.8% | +7.5% | -7.5% |
| CDMO | SELL | 2023-01-10 | 2023-01-11 | $14.44 | $22K | +9.4% | +6.3% | +30.5% |
| CDMO | SELL | 2022-10-10 | 2022-10-11 | $17.90 | $23K | -13.1% | -17.8% | -18.3% |
| CDMO | SELL | 2022-07-11 | 2022-07-12 | $17.75 | $77K | +0.8% | +9.1% | +2.3% |
| CDMO | SELL | 2022-07-08 | 2022-07-11 | $17.53 | $145K | +10.8% | +8.4% | +0.0% |
| CDMO | SELL | 2022-04-11 | 2022-04-12 | $18.56 | $13K | -8.8% | -34.5% | -3.5% |
| CDMO | SELL | 2022-01-10 | 2022-01-11 | $21.58 | $19K | -19.2% | -5.2% | -18.4% |
| CDMO | SELL · 10b5-1 | 2022-01-03 | 2022-01-05 | $29.07 | $15K | -16.2% | -16.2% | -15.4% |
| CDMO | SELL | 2021-10-11 | 2021-10-12 | $22.37 | $17K | +11.9% | +43.8% | -3.6% |
| CDMO | SELL | 2021-07-12 | 2021-07-13 | $25.61 | $277K | +1.4% | -3.2% | -10.8% |
| CDMO | SELL | 2020-07-13 | 2020-07-14 | $6.88 | $14K | -5.8% | +15.3% | +7.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.